Lucid Diagnostics Share Price Today (NASDAQ: LUCD)

Name: Lucid Diagnostics Share Price (NASDAQ: LUCD) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Lucid Diagnostics share price is $1.29 & ₹111.02 as on 14 Jun 2025, 01.29 hrs IST

$1.29

▲

-0.02

(-1.53%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Lucid Diagnostics share price in Dollar and Rupees. Guide to invest in Lucid Diagnostics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lucid Diagnostics, along with analyst recommendations, forecasts, and comprehensive financials.

Lucid Diagnostics share price movements

Today's Low: $1.29
Today's High: $1.34
$1.29
0.39%
Downside
Day's Volatility :3.75%
Upside
3.37%
52 Weeks Low: $0.68
52 Weeks High: $1.80
$1.29
47.21%
Downside
52 Weeks Volatility :62.17%
Upside
28.33%

Lucid Diagnostics (LUCD) Returns

Period	Lucid Diagnostics Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.9%	-6.1%	0.0%
6 Months	60.51%	-3.4%	0.0%
1 Year	73.13%	-6.7%	0.0%
3 Years	-28.06%	13.0%	3.6%

Lucid Diagnostics (LUCD) Key Statistics

in dollars & INR

Previous Close	$1.31
Open	$1.3
Today's High	$1.335
Today's Low	$1.285
Market Capitalization	$138.5M
Today's Volume	$744.5K
52 Week High	$1.8
52 Week Low	$0.681
Revenue TTM	$4.2M
EBITDA	$-46.9M
Earnings Per Share (EPS)	$-1.15
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1897.35%

How to invest in Lucid Diagnostics Stock (LUCD) from India?

It is very easy for Indian residents to invest directly in Lucid Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lucid Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lucid Diagnostics or LUCD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lucid Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lucid Diagnostics shares which would translate to 0.667 fractional shares of Lucid Diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Lucid Diagnostics, in just a few clicks!

Returns in Lucid Diagnostics (LUCD) for Indian investors in Rupees

The Lucid Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lucid Diagnostics investment value today

Current value as on today

₹1,75,039

Returns

₹75,039

(+75.04%)

Returns from Lucid Diagnostics Stock

₹72,000 (+72%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Lucid Diagnostics (LUCD)

-15%

Period: May 14, 2025 to Jun 13, 2025. Change in 30 Days versus previous period

Search interest for Lucid Diagnostics Stock from India on INDmoney has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lucid Diagnostics

Masters Capital Management LLC
2.52%
Alyeska Investment Group, L.P.
1.74%
Vanguard Group Inc
0.82%
Renaissance Technologies Corp
0.42%
Luminus Management, LLC
0.42%
Ghisallo Capital Management LLC
0.39%

Analyst Recommendation on Lucid Diagnostics

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Lucid Diagnostics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Lucid Diagnostics Stock (LUCD)

What analysts predicted

Upside of 193.93%

Target:

$3.79

Current:

$1.29

Insights on Lucid Diagnostics Stock (Ticker Symbol: LUCD)

Price Movement
In the last 6 months, LUCD stock has moved up by 64.9%
Increasing Revenue
Revenue is up for the last 4 quarters, 976.0K → 828.0M (in $), with an average increase of 39.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -11.54M → -36.01B (in $), with an average decrease of 311987.3% per quarter
LUCD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 31.7% return, outperforming this stock by 60.9%

Lucid Diagnostics Technicals Summary

Sell

Neutral

Buy

Lucid Diagnostics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lucid Diagnostics (LUCD) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lucid Diagnostics Inc.	5.28%	60.51%	73.13%	-28.06%	-88.99%
Medtronic Plc	1.34%	7.26%	7.68%	-2.34%	-6.79%
Edwards Lifesciences Corp.	-2.26%	1.66%	-13.92%	-15.36%	8.96%
Boston Scientific Corp.	-4.95%	10.18%	29.84%	176.62%	177.85%
Stryker Corporation	-3.81%	1.22%	9.35%	86.29%	100.15%
Abbott Laboratories	1.7%	20.42%	30.81%	29.41%	51.45%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lucid Diagnostics Inc.	NA	NA	NA	-0.43	-18.97	-0.92	NA	-0.71
Medtronic Plc	24.39	24.39	2.51	5.46	0.1	0.05	0.03	37.46
Edwards Lifesciences Corp.	31.05	31.05	4.23	2.47	0.17	0.08	NA	17.28
Boston Scientific Corp.	72.55	72.55	2.46	2.92	0.1	0.05	NA	15.02
Stryker Corporation	52.06	52.06	2.23	13.34	0.14	0.07	0.01	54.77
Abbott Laboratories	17.61	17.61	4.17	5.16	0.31	0.06	0.02	28.06

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lucid Diagnostics Inc.	Buy	$138.5M	-88.99%	NA	0.0%
Medtronic Plc	Buy	$112.9B	-6.79%	24.39	13.9%
Edwards Lifesciences Corp.	Buy	$44.1B	8.96%	31.05	75.71%
Boston Scientific Corp.	Buy	$147.1B	177.85%	72.55	11.58%
Stryker Corporation	Buy	$145.6B	100.15%	52.06	12.31%
Abbott Laboratories	Buy	$236.0B	51.45%	17.61	31.89%

About Lucid Diagnostics

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Organization	Lucid Diagnostics
Employees	72
CEO	Dr. Lishan Aklog M.D.
Industry	Healthcare

Management People of Lucid Diagnostics

Name	Title
Dr. Lishan Aklog M.D.	Chairman & CEO
Mr. Shaun M. O'Neill M.B.A.	President & COO
Mr. Michael Adam Gordon	General Counsel & Secretary
Dr. Sanford D. Markowitz M.D., Ph.D.	Co-Founder & Strategic Advisor
Dr. Joseph Willis M.D.	Co-founder & Strategic Advisor
Dr. Amitabh Chak M.D.	Co-Founder & Strategic Advisor
Helen Moinova Ph.D.	Co-Founder & Strategic Advisor
Dr. Brian J. deGuzman M.D.	Chief Technology & Compliance Officer
Dr. Suman M. Verma M.D., Ph.D.	Chief Scientific Officer
Mr. Matthew Riley	Director of Investor Relations

Important FAQs about investing in LUCD Stock from India :

Can Indians buy Lucid Diagnostics shares?

Yes, Indians can invest in the Lucid Diagnostics (LUCD) from India.

With INDmoney, you can buy Lucid Diagnostics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lucid Diagnostics at zero transaction cost.

How can I buy Lucid Diagnostics shares from India?

It is very easy to buy Lucid Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lucid Diagnostics (LUCD) be purchased?

Yes, you can buy fractional shares of Lucid Diagnostics with INDmoney app.

What are the documents required to start investing in Lucid Diagnostics stocks?

To start investing in Lucid Diagnostics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Lucid Diagnostics share price today?

Lucid Diagnostics share price today stands at $1.29, Open: $1.30 ; Previous Close: $1.31 ; High: $1.34 ; Low: $1.29 ; 52 Week High: $1.80 ; 52 Week Low: $0.68.

The stock opens at $1.30, after a closing price of $1.31. The stock reached a daily high of $1.34 and a low of $1.29, with a 52-week high of $1.80 and a 52-week low of $0.68.